Wantai Biological Announces Resolutions from First Extraordinary General Meeting of 2026
Deep News
Sep 23
On September 23, Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. issued a notice confirming that its first extraordinary general meeting for 2026 was held on the same day.
At the meeting, shareholders approved a proposal to terminate certain funded projects and redirect the use of the raised capital to new purposes.
The resolution, titled "Proposal to Terminate Partial Fundraising Investment Projects and Change the Use of Raised Funds," passed as part of the company's ongoing strategic adjustments.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.